Chemistry: molecular biology and microbiology – Differentiated tissue or organ other than blood – per se – or... – Including perfusion; composition therefor
Reexamination Certificate
2005-12-20
2005-12-20
Saucier, Sandra E. (Department: 1651)
Chemistry: molecular biology and microbiology
Differentiated tissue or organ other than blood, per se, or...
Including perfusion; composition therefor
Reexamination Certificate
active
06977140
ABSTRACT:
An organ perfusion apparatus and method monitor, sustain and/or restore viability of organs and preserve organs for storage and/or transport. The method includes perfusing the organ at hypothermic and/or normothermic temperatures, preferably after hypothermic organ flushing for organ transport and/or storage. The method can be practiced with prior or subsequent static or perfusion hypothermic exposure of the organ. Organ viability is restored by restoring high energy nucleotide (e.g., ATP) levels by perfusing the organ with a medical fluid, such as an oxygenated cross-linked hemoglobin-based bicarbonate medical fluid, at normothermic temperatures. In perfusion, organ perfusion pressure is preferably controlled in response to a sensor disposed in an end of tubing placed in the organ, by a pneumatically pressurized medical fluid reservoir, providing perfusion pressure fine tuning, overpressurization prevention and emergency flow cut-off. In the hypothermic mode, the organ is perfused with a medical fluid, preferably a simple crystalloid solution containing antioxidants, intermittently or in slow continuous flow. The medical fluid may be fed into the organ from an intermediary tank having a low pressure head to avoid organ overpressurization. Preventing overpressurization prevents or reduces damage to vascular endothelial lining and to organ tissue in general. Viability of the organ may be automatically monitored, preferably by monitoring characteristics of the medical fluid perfusate. The perfusion process can be automatically controlled using a control program.
REFERENCES:
patent: 5450329 (1995-09-01), Tanner et al.
patent: 5586438 (1996-12-01), Fahy
patent: 88/05261 (1988-07-01), None
patent: 96/29865 (1996-10-01), None
patent: 97/43899 (1997-11-01), None
patent: WO 01/01774 (2001-01-01), None
Ingwall et al., “Fetal Mouse Hearts. Model for Studying Ischemia”, PNAS 72 (7) : 2809-13 (1975).
Burdon et al., “Cell Proliferation and Oxidative Stress”, Free Radical Research Communications 7 (3-6) : 149-59 (1989).
Chambers et al., “Free Radicals and Cardioplegia: Organic Anti-Oxidants as additives to the St. Thomas' Hospital cardioplegic Solution”, Cardiovascular Research 23 (4) : 351-8 (1989).
Michael J. Taylor et al.; “Hypothermia in Relation to the Acceptable Limits of Ischemia for Bloodless Surgery”; Advances in Low-Temperature Biology; vol. 3; pp. 1-64; 1996.
Kravitz David C.
Owen Donald R.
Oliff & Berridg,e PLC
Organ Recovery Systems, Inc.
Saucier Sandra E.
LandOfFree
Method for maintaining and/or restoring viability of organs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for maintaining and/or restoring viability of organs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for maintaining and/or restoring viability of organs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3489137